FLUORESCENCE GUIDED SURGERY SYSTEMS MARKET ANALYSIS

Regional Analysis

Global Fluorescence Guided Surgery Systems Market: Regional Insights

Based on geography, the global fluorescence guided surgery systems market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market over the forecast period owing to the rise in the prevalence of cancer and cardiovascular diseases in this region. For instance, fluorescence guided surgery has recently been introduced into cancer surgery and could potentially change the future of oncological procedures. According to the American Cancer Society (ACS), there will be an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States in 2022. This in turn is expected to aid in the growth of the global fluorescence guided surgery systems market.

Asia Pacific is also expected to witness robust growth in the global fluorescence guided surgery systems market due to the growing burden of cancers and increase in the number of surgical procedures in this region. For instance, India’s cancer cases could increase by 12% in the next five years, with 1.5 million people projected to suffer from the non-communicable disease by 2025, up from 1.39 million in 2020, according to data based on current trends from the cancer report by Indian Council of Medical Research (ICMR).

Fluorescence Guided Surgery Systems Market Report Coverage

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa